Results 221 to 230 of about 123,214 (256)
Some of the next articles are maybe not open access.

Heart failure with reduced ejection fraction

The Lancet
Heart failure is a complex clinical syndrome affecting around 70 million individuals globally. It has a prevalence of 2% in Europe and North America and approximately 1% in Asia and South America. Accurate diagnosis relies on the presence of typical signs and symptoms, elevated natriuretic peptide concentrations, and evidence of cardiac structural or ...
Antonio, Cannata   +4 more
openaire   +4 more sources

Hypertension in Patients with Heart Failure with Reduced Ejection Fraction

Current Cardiology Reports, 2016
Hypertension (HTN) is a well-known health problem associated with considerable morbidity and mortality and it is an important risk factor for the development of heart failure (HF). These findings support the need for optimizing the antihypertensive strategies to prevent the progression to HF.
VOLPE, Massimo   +2 more
openaire   +2 more sources

  blockers for heart failure with reduced ejection fraction

BMJ, 2011
#### Case scenario A 74 year old man attends the surgery for review of his longstanding heart failure. He has an exercise tolerance of just a few yards, limited by breathlessness. His jugular venous pressure is not raised, he has no ankle oedema, and the lung bases are clear. There is no evidence of fluid overload.
Derek G, Waller, James R, Waller
openaire   +2 more sources

Biomarkers of Heart Failure with Preserved and Reduced Ejection Fraction

2016
Biomarkers are increaingly being used in the management of heart failure not only for the purpose of screening, diagnosis, and risk stratification, but also as a guide to evaluate the response to treatment in the individual patient and as an entry criterion and/or a surrogate marker of efficacy in clinical trials testing novel drugs.
Senni M.   +3 more
openaire   +2 more sources

Ventricular arrhythmias in heart failure with reduced ejection fraction

Current Opinion in Cardiology, 2020
Purpose of review To provide a framework for approaching ventricular arrhythmias in the setting of cardiomyopathy, outline the latest evidence-based recommendations for catheter ablation and device therapy, and discuss novel treatment strategies.
Aleksandr, Voskoboinik, Joshua D, Moss
openaire   +2 more sources

[Reduced ejection fraction heart failure].

Revue medicale de Liege, 2022
This clinical vignette discusses the recommendations for the management of heart failure with reduced ejection fraction. Unlike the old guidelines, it is currently indicated to start all pharmacological treatments that have proven to be effective in terms of morbidity and mortality at the same time and as quickly as possible.
A, Ancion   +2 more
openaire   +1 more source

Heart Failure: Heart Failure With Reduced Ejection Fraction.

FP essentials, 2021
Heart failure (HF) with reduced ejection fraction (HFrEF) is becoming more prevalent as the US population ages. Although the clinical presentation of HFrEF is remarkably similar to that of HF with preserved ejection fraction (HFpEF), the primary etiology may be different.
openaire   +1 more source

Heart Failure with Reduced Ejection Fraction

2019
Heart failure with reduced ejection fraction (HF-REF) is a common problem worldwide and its prevalence rises with age. It is associated with substantial morbidity and mortality. Development of the condition is driven by a number of haemodynamic and neurohumoral pathophysiological processes which, in turn, lead to adverse remodelling of the myocardium ...
Alice M. Jackson, Pardeep S. Jhund
openaire   +1 more source

Heart failure with preserved ejection fraction: A precursor of heart failure with reduced ejection fraction or a distinct syndrome?

International Journal of Cardiology, 2011
[1] Cooper A, Calvert N, SKinner J, et al. Nice guideline: chest pain of recent onset: assessment of recent onset chest pain or discomfort of suspected cardiac origin; 2010. available at:http://www.nice.org.uk/nicemedia/live/12947/47931/47931.pdf. [2] Bourdillon PJ. NICE and chest pain diagnosis.
Daniela, Miani   +6 more
openaire   +2 more sources

New pharmacotherapy for heart failure with reduced ejection fraction

Expert Review of Cardiovascular Therapy, 2020
The European Society of Cardiology (ESC), Canadian Cardiovascular Society, and the American College of Cardiology Heart Failure (HF) guidelines all currently recommend the use of Angiotensin Converting Enzyme (ACE) inhibitors or Angiotensin Receptor Blockers (ARBs) and Beta Blockers (BB) in the treatment of HF with a reduced ejection fraction (HFrEF ...
Sara Sotirakos   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy